Security key
28617K101
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)
CUSIP: 28617K101
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 78,762,953
- Total 13F shares
- 7,004,967
- Share change
- -879,743
- Total reported value
- $27,598,192
- Price per share
- $3.94
- Number of holders
- 30
- Value change
- -$4,350,190
- Number of buys
- 9
- Number of sells
- 13
Report period
Q1 2022
Institutions
30
Top holders
10
ELDN full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Eledon Pharmaceuticals, Inc. SEC filings
Eledon Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 28617K101
Recent filing periods:
Top shareholders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
1.7%
|
1,378,020
|
$6,077,000 | — | 31 Dec 2021 | |
| Logos Global Management LP |
13F
|
Company |
1.7%
|
1,339,793
|
$5,908,000 | — | 31 Dec 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.7%
|
1,305,095
|
$5,755,000 | — | 31 Dec 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.99%
|
781,376
|
$3,446,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.85%
|
669,700
|
$2,953,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
0.64%
|
504,371
|
$2,224,000 | — | 31 Dec 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.55%
|
431,435
|
$1,903,000 | — | 31 Dec 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.44%
|
344,578
|
$1,519,000 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.16%
|
127,600
|
$563,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
126,710
|
$558,000 | — | 31 Dec 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.16%
|
125,193
|
$552,000 | — | 31 Dec 2021 | |
| CM Management, LLC |
13F
|
Company |
0.15%
|
115,000
|
$507,000 | — | 31 Dec 2021 | |
| Eversept Partners, LP |
13F
|
Company |
0.14%
|
114,008
|
$502,775 | — | 31 Dec 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.1%
|
77,100
|
$340,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.08%
|
63,166
|
$279,000 | — | 31 Dec 2021 | |
| JMAC ENTERPRISES LLC |
13F
|
Company |
0.07%
|
54,538
|
$216,000 | — | 31 Dec 2021 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
0.06%
|
51,149
|
$226,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
40,435
|
$178,000 | — | 31 Dec 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
36,242
|
$160,000 | — | 31 Dec 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
34,630
|
$153,000 | — | 31 Dec 2021 | |
| Veritable, L.P. |
13F
|
Company |
0.04%
|
33,092
|
$146,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
30,053
|
$133,000 | — | 31 Dec 2021 | |
| Ameritas Advisory Services, LLC |
13F
|
Company |
0.03%
|
24,219
|
$107,000 | — | 31 Dec 2021 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
16,726
|
$74,000 | — | 31 Dec 2021 | |
| MERCER GLOBAL ADVISORS INC /ADV |
13F
|
Company |
0.02%
|
16,726
|
$74,000 | — | 31 Dec 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
13,673
|
$60,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
10,174
|
$45,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
8,770
|
$39,000 | — | 31 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,638
|
$16,000 | — | 31 Dec 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
2,717
|
$11,000 | — | 31 Dec 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,056
|
$9,000 | — | 31 Dec 2021 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0%
|
1,666
|
$7,000 | — | 31 Dec 2021 | |
| Spire Wealth Management |
13F
|
Company |
0%
|
850
|
$4,000 | — | 31 Dec 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
211
|
$1,000 | — | 31 Dec 2021 |
Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) as of Q1 2022
As of 31 Mar 2022,
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,004,967 shares.
The largest 10 holders included
BVF INC/IL, Cormorant Asset Management, LP, VANGUARD GROUP INC, Woodline Partners LP, Point72 Asset Management, L.P., Ikarian Capital, LLC, CM Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Eversept Partners, LP, and TWO SIGMA ADVISERS, LP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
34
Q1 2022 holders
30
Holder diff
-4
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.